David Zaccardelli, President and CEO at Verona Pharma plc (VRNA), sold 506,904 shares at $0.64 ($324K) on 2021-11-02, disclosed to the SEC on 2021-11-03.
Scheduled sale ($324k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.64 | 454,848 | $291K | 89.7% |
| 2 | $0.64 | 52,056 | $33K | 10.3% |
| Total | $0.64 avg | 506,904 | $324K | 100% |
| Filing → |
| VRNA | SELL | 2025-05-29 | $7.1M | — | Filing → |
| VRNA | SELL | 2025-05-05 | $7.0M | — | Filing → |
| VRNA | SELL | 2025-05-01 | $1.6M | — | Filing → |